Plasma-derived vitamin D binding protein (DBP) is an important physiologic regulator of the neutrophil chemotactic response to activated complement. A cell-associated form of DBP has been observed in numerous cell types. We now report that mature, circulating human neutrophils also contain cell-associated DBP. Immunofluorescence studies of normal untreated neutrophils showed the presence of DBP on the cell surface. Western blotting of detergent-soluble neutrophil lysates with a polyclonal anti-DBP showed two major immunoreactive bands, one with an apparent molecular weight of 56 Kd (identical to purified plasmaderived DBP) and a second less prominent band at 12 to 14 Kd. Quantitation of the immunoreactive bands by video densitometry indicated that normal human neutrophils contain 1.5 -C 0.8 ng DBP/106 cells (n = 9). Immunoprecipitation of detergent-soluble lysates with the polyclonal HE VITAMIN D binding protein (DBP), also known as T Gc-globulin, is a plasma protein that has the capacity to bind several diverse ligands including vitamin D sterols, unsaturated fatty acids, G-actin and the complement activation peptides C5a and C5a des Arg (reviewed by Cooke and Haddad).' DBP is a highly polymorphic protein with three common isotypes and more than 120 minor isotypic varianb2 The protein is expressed as a single polypeptide chain with a molecular weight of approximately 56 Kd and circulates in plasma with a concentration of 6 to 7 pmol/L.' DBP is a member of the albumin and a-fetoprotein gene family and shares considerable amino acid homology with these protein^.^,^ Besides functioning as a circulating vitamin D transport protein, it has been shown that plasma DBP effectively scavenges G-actin released at sites of cell injury and/or death and prevents polymerization of actin filaments in the Recently, DBP also has been shown to be the serum-derived macrophage-activating factor.9-" It is interesting to note that homozygous deficiency of DBP has never been observed in nearly 100,000 individuals examined world-wide; such a deficiency is thought to be incompatible with life.* Numerous investigators also anti-DBP showed only the 56-Kd form by Western blotting. In contrast, a monoclonal anti-DBP immunoprecipitated the 12 to 1 4 Kd form of DBP from lysates of surfaceradioiodinated cells. Western blots of subcellular fractions showed that immunoreactive bands were found in the specific (secondary) granule and plasma-membrane fractions. In addition, pretreatment of neutrophils with 10 nmol/L phorbol myristate acetate (PMA) resulted in approximately a 50% reduction in the amount of DBP in both the specific granule and plasma-membrane fractions. Finally, analysis of the cell-free supernates showed that DBP wasspontaneously released into the extracellular milieu: moreover, this release was enhanced if the cells were first stimulated with C5a, formyl-norleucyl-leucyl-phenylalanine (fNLP) or PMA. have reported a cell-associated form of DBP. Using immunofluorescent or radioisotope techniques, these studies have shown that DBP is localized to the plasma membrane of human blood monocytes and lymphocyte^,'^-'^ human placental trophoblast and smooth muscle cell^,'^^'^ rat pancreatic acinar cells,I7 and porcine kidney tubule cells." Recently, Guoth et all9 have convincingly shown in the human monocytic cell line U937 that cell-surface DBP is derived from plasma (or serum) and not synthesized de novo. In addition to its cell-surface localization, intracellular DBP has been detected in normal human lymphocyte^.*^*^^ In contrast, it has been shown that microinjection of purified DBP into the cytoplasm of nonmuscle cells will produce massive (but reversible) disruption of the microfilament organization.21 Although cell-associated DBP appears to be ubiquitously distributed, numerous questions remain concerning its cell surface binding site (receptor), metabolism, and function.
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have reported a cell-associated form of DBP. Using immunofluorescent or radioisotope techniques, these studies have shown that DBP is localized to the plasma membrane of human blood monocytes and lymphocyte^,'^-'^ human placental trophoblast and smooth muscle cell^,'^^'^ rat pancreatic acinar cells,I7 and porcine kidney tubule cells." Recently, Guoth et all9 have convincingly shown in the human monocytic cell line U937 that cell-surface DBP is derived from plasma (or serum) and not synthesized de novo. In addition to its cell-surface localization, intracellular DBP has been detected in normal human lymphocyte^.*^*^^ In contrast, it has been shown that microinjection of purified DBP into the cytoplasm of nonmuscle cells will produce massive (but reversible) disruption of the microfilament organization. 21 Although cell-associated DBP appears to be ubiquitously distributed, numerous questions remain concerning its cell surface binding site (receptor), metabolism, and function.
Previously, we and Perez et a122, 23 have shown that DBP can bind C5a and its metabolite C5a des Arg and enhance their chemotactic activity for neutrophils. In addition, it was shown by immunologic cross-reactivity and amino acid sequence analysis that DBP is identical to a plasma-derived protein formerly known as c o~h e m o t a x i n . ~~ Recently, several other groups have confirmed our observations that DBP can augment the neutrophil chemotactic activity of C5a and C5a des Arg and may modulate the recruitment of neutrophils to sites of i n f l a m m a t i~n .~~-~~ Although DBP appears to be a physiologically important regulator of neutrophil chemotactic activity for activated complement, the mechanism of chemotactic enhancement is not known. To address this question we have begun to investigate the interaction of DBP-CSa complexes with human neutrophils. However, these studies have been complicated by the observation that neutrophils, like many other cells, contain an endogenous DBP. Because little is known about cell-associated DBP in human neutrophils, we initiated an investigation to quantitate and localize neutrophil-associated DBP. We report here that human neutrophils contain approxi- For personal use only. on November 16, 2017. by guest www.bloodjournal.org From NEUTROPHIL-ASSOCIATED DBP 275 mately 1.5 ng DBP/ IO6 cells. The majority of the cell-associated DBP has a molecular weight identical to plasmaderived DBP (56 Kd) and is found in subcellular fractions that contain markers for the plasma membranes and specific (secondary) granules. Furthermore, it appears that stimulation of neutrophils causes upregulation of DBP from the intracellular pool to the cell surface and the extracellular milieu. We believe that this information is critical to begin to examine the potential role that DBP may play in neutrophil chemotaxis.
MATERIALS AND METHODS
Purified human DBP was purchased from Calbiochem (San Diego, CA) and from Biodesign International (Kennebunkport, ME). The formylated chemotactic tripeptides formyl-methionyl-leucyl-phenylalanine (fMLP) and formylnorleucyl-leucyl-phenylalanine (fNLP) were purchased from Bachem (Torrance, CA). C5a was purified from zymosan-activated human serum as previously described." Phorbol myristate acetate (PMA), cytochalasin D (cyto D), phenylmethylsulfonyl fluoride (PMSF), and 1,lO-phenanthroline were purchased from Sigma Chemical Co (St Louis, MO). All other protease inhibitors were purchased from Bachem.
Goat antibodies to human DBP (IgG fraction) were purchased from Atlantic Antibodies (Incstar Corp, Stillwater, MN). Mouse monoclonal antibody (MoAb) (IgG,) to human DBP (MAK 89) was a generous gift from Dr John Haddad, University of Pennsylvania (Philadelphia, PA). Mouse MoAb to actin (KJ43A) and affinity-purified, alkaline phosphatase-conjugated secondary antibodies (goat antimouse IgG and rabbit antigoat IgG), preabsorbed against human serum, were purchased from Sigma Chemical Co. Fluorescein isothiocyanate (F1TC)-conjugated rabbit F(ab), antigoat IgG, preabsorbed against human serum, was purchased from Accurate Scientific (Westbury, NY).
Isolation of human neutrophils. Neutrophils were isolated at room temperature (22°C) from the venous blood of healthy, medication-free, paid volunteers who gave informed consent.27 This procedure was approved by the Institutional Review Board of SUNY at Stony Brook, NY in accordance with assurance filed with, and a p proved by, the US Department of Health and Human Services. Briefly, heparinized blood ( I O U/mL) was treated with an equal volume of 3% Dextran T-500 (Pharmacia-LKB, Piscataway, NJ), prepared in sterile, pyrogen-free saline, for 30 minutes to sediment the red blood cells (RBCs). After washing the cells in phosphatebuffered saline (PBS) the leukocyte-rich pellet was centrifuged through an endotoxin-free Lymphoprep (Accurate Scientific) gradient (400g for 30 minutes at 22°C) to separate the mononuclear leukocytes from the neutrophils. The neutrophil-rich pellet was resuspended in PBS and exposed to hypotonic conditions (75 mosM) using sterile, pyrogen-free water for 60 seconds to lyse any contaminating RBCs. Neutrophils were then washed twice in PBS, counted, and then placed on ice until used (usually within 30 minutes). A typical cell preparation contained 98% neutrophils, I % eosinophils, and I% mononuclear cells and were 98% to 99% viable by trypan blue dye exclusion.
Detection of cell-suvface DBP by immunofluorescence. Untreated normal human neutrophils (IO' cells) were allowed to adhere to poly-1-lysine-coated glass slides for 30 minutes at 4°C. Nonadherent cells were removed by washing 3 times with PBS. Neutrophils next were treated with IO pg/mL of goat antihuman DBP or nonimmune goat IgG (both prepared in PBS + 1% bovine serum albumin [BSA]) for 60 minutes at 4°C. Cells were then washed 4 times with PBS-BSA and treated with 1 pg/mL FITC-con-
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jugated rabbit F(ab), antigoat IgG for 60 minutes at 4°C. After washing the cells 5 times with PBS-BSA, neutrophils were fixed in 4% paraformaldehyde in PBS for 30 minutes at 22°C. Finally, cells were washed with PBS and then mounted with 90% glycerol, 10% PBS containing 1 mg/mL p-phenylenediamine (to inhibit autofluorescence and enhance nuclear morphology), and examined at original magnification x 1,000.
Preparation of neutrophillysates andreleasates. Detergent-soluble lysates of neutrophils were prepared by pelleting (400g for 10 minutes at I O T ) 50 X IO6 cells in a 1.5-mL microfuge tube. After the PBS supernate was removed, the cells were lysed by adding 100 pL of 2% Nonidet P-40 (NP-40) (Sigma), 50 mmol/L HEPES (pH 7.5) containing 20 mmol/L benzamidine, 10 mmol/L EDTA, 10 mmol/L NaN,, as well as the followinginhibitorsaddedfresh immediately before lysis: 2 mmol/L PMSF, 2 mmol/L I, IO-phenanthroline, 0.5 mmol/L E-64, 0.1 mmol/L leupeptin, and 0.1 mmol/L pepstatin. Lysates were vortexed thoroughly until all particulate matter was solubilized (usually 5 to 10 seconds) and then placed on ice for 30 minutes. The detergent-insoluble material was then pelleted by spinning the lysates in a microfuge for 10 minutes at 15,OOOg at 4°C. The detergent-soluble lysate was carefully removed Supernates of neutrophils stimulated to release the contents of their cytoplasmic granules (ie, releasates) were prepared as follows: cells (2.5 X 10') were resuspended in 0.5 mL ofHanks' balanced salt solution (HBSS) and treated with either buffer, 1 pmol/L fNLP, 10 nmol/L C5a, or 10 nmol/L PMA for 45 minutes in a 37°C water bath with constant shaking. The releasate (cell-free supernate) then was collected after centrifuging the cell preparations 4008 for 10 minutes at 4°C. Aliquots ofthe releasate were prepared for electrophoresis by boiling with an equal volume of sample buffer (see above). The cell pellets were solubilized in 2% NP-40 lysis buffer containing the protease inhibitor cocktail and prepared for electrophoresis as described above.
Cell disruption and subcellular fractionation. Freshly isolated neutrophils were disrupted by nitrogen cavitation and subcellular fractions were then subsequently isolated by centrifuging through discontinuous Percoll gradients (Pharmacia-LKB)?' Briefly, 2.5 X 10' cells were resuspended in 5 mL of disruption buffer that contained 100 mmol/L KCl, 3 mmol/L NaC1, 3.5 mmol/L MgCl,, 1 mmol/L adenosine triphosphate (ATP), and 10 mmol/L HEPES (pH 7.3). The following protease inhibitors were then added just before disruption: 2 mmol/L PMSF, 2 mmol/L 1, IO-phenanthroline, 0.5 mmol/L E-64, 0.1 mmol/L leupeptin, and 0.1 mmol/L pepstatin. Cells were pressurized to 350 psi using ultrapure nitrogen gas in a cell-disruption bomb (Parr Instrument Co, Moline, IL) for 20 minutes at 4°C with constant stirring. The disrupted cells were collected dropwise into a tube that contained EGTA (final concentration of 1.25 mmol/L). Unbroken cells (typically <5% of total) and the nuclei were removed by centrifugation at SOOg for 15 minutes at 4°C. The nuclear fraction was prepared by resuspending the nuclei in 1% NP-40,25 mmol/L HEPES (pH 7.4), adding 10 p g of mammalian DNAase I (Boehringer Mannheim, Indianapolis, IN), and incubating for 10 minutes at 37°C. The postnuclear supernate was then carefully layered on top of a discontinuous gradient of Percoll that consisted of 6 mL of 1.05 g/mL underlayered with 6 mL of 1.12 g/mL Percoll prepared in disruption buffer. Samples were spun for 20 minutes at 4°C at 48,OOOg using a Sorvall RC2-B centrifuge (E.I. duPont de Nemours, Chadds Ford, PA) with an SS-34 rotor. The cytosol, plasma membrane, specific granules, and
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From azurophil granules were collected separately and Percoll was removed by spinning the samples at 210,OOOg for 30 minutes at 4°C using a Beckman TL-100 ultracentrifuge (Beckman Instruments, Palo Alto, CA). Granule fractions were disrupted by adding Triton X-100 (Sigma) to a final concentration of0.5%. PMSF (2 mmol/L) and 2 mmol/L 1, IO-phenanthroline were also added to the granules during the detergent lysis.
The five subcellular fractions (nuclear, cytosol, membrane, specific granule, and azurophil granule) were assayed for total protein using the Pierce Bicinchoninic acid (BCA) reagent (Pierce Chemical Co, Rockford, IL). Alkaline phosphatase (plasma-membrane marker), lactate dehydrogenase (cytosol marker), vitamin B,, binding protein (specific granule marker), and myeloperoxidase (azurophi1 granule marker) were also measured in each sample to determine the purity of each fraction. Alkaline phosphatase and lactate dehydrogenase were measured using commercial diagnostic kits (Sigma Chemical Co). Vitamin B,, binding protein was quantitated using 57C0 vitamin B,, (Amersham, Arlington Heights, IL)29 and myeloperoxidase was measured using o-dianisidine as previously described."
Cell-surface radioiodination and immunoprecipitation. Cellsurface proteins were radioiodinated using IZ5I-Na by a soluble glucose oxidase-lactoperoxidase method.,' Briefly, 50 X IO6 neutrophils were resuspended in I mL of PBS containing 0.1 % dextrose and placed on ice. The iodination reaction was initiated by adding 1 mCi of 1251-Na (Dupont-NEN, Boston, MA), 32-pg lactoperoxidase (Sigma), and 0.01 U glucose oxidase (Sigma) for 30 minutes on ice. The reaction was terminated by washing the cells three times in ice-cold PBS containing 10 mmol/L Kl. After one wash in PBS, the cells were transferred to a 1.5-mL microfuge tube, pelleted, and lysed as above in NP-40 lysis buffer containing the protease inhibitor cocktail, except that the NP-40 concentration was 0.5%. The detergent-insoluble material was then removed by centrifuging the lysates in a microfuge for I O minutes at 15,OOOg at 4°C.
Before immunoprecipitation, lysates first were precleared by incubating with 200 pg nonimmune IgG (either goat or mouse) for 4 hours at 4°C. The IgG was then removed by adding the lysate directly to 50 pL of packed Protein-G Sepharose (Pharmacia-LKB) for 2 hours at 4°C. DBP was immunoprecipitated from precleared detergent-soluble lysates by adding either 20 pg of the MAK 89 MoAb or 50 pg ofthe goat polyclonal antibody and incubating for 4 hours at 4°C. The immune complexes were then removed by adding the anti-DBP lysate mixture to 25 pL of pelleted Protein-G Sepharose and incubating for 2 hours at 4°C. The protein-G beads were washed five times in 0.5% NP-40 lysis buffer, five times in 0.6 mol/L NaCI, 10 mmol/L NaPO, (pH 7.5), and twice in PBS. Electrophoresis sample buffer was added directly to the protein-G beads. After boiling the samples for 7 minutes the supernate was removed for electrophoretic analysis.
Polyacrylamide gel electrophoresis (PAGE) and Western blotting. The contents of the detergent-solubilized lysates were separated by PAGE in the presence of SDS (SDS-PAGE) using the discontinuous buffer system described by Laemmli." To assure complete disulfide reduction of DBP (which contains 14 disulfide bonds), all samples were prepared for electrophoresis by boiling in an SDS-PAGE sample buffer (2% SDS) containing 0.2 mol/L DTT added fresh immediately before preparation. Samples were separated on a mini-gel apparatus (Bio-Rad, Richmond, CA). The separated proteins were transferred from the gel, at 12 V (constant voltage) for 30 minutes at 22"C, to 0.45 pm pore size polyvinylidene fluoride (PVDF) paper (Westran, Schleicher & Schuell, Keene, NH) using a semi-dry blotting apparatus (TransBlot SD; Bio-Rad). The blots were then incubated in a solution of 5% nonfat dry milk (BLOTTO) in PBS for 60 minutes at 22°C to block unreacted protein binding sites and washed briefly in PBS containing 0.1% Tween-20 (Sigma) and 0.025% NaN, (PBS-Tween). The primary antibody (1 to IO pg/mL diluted in PBS-Tween) was then added and the blot was incubated for 16 hours at 22°C. After washing four times in PBS-Tween, the blot was added to an affinity-purified secondary antibody conjugated to alkaline phosphatase (1 pg/mL prepared in PBS-Tween) and incubated for 4 hours at 22°C. Finally, the blots were washed five times in PBS-Tween, twice in substrate buffer (0.1 mol/L Tris [pH 9.51, 0.1 mol/L NaCI, 5 mmol/L MgCI,), and then incubated in a 1.5 dilution of a one component 5 -bromo -4-chloro-3 -indolyl -phosphate/nitroblue tetrazolium (BCIP/NBT) phosphatase substrate (Kirkegaard & Perry Laboratories, Gaithersburg, MD) at 22°C until bands were visible (usually within 5 minutes).
Quantitation by densitometry. Blots and/or photographic positives ofblots were subjected to densitometry using a Bio-Rad model 620 video densitometer linked to a Apple Macintosh IIcx computer (Apple Computers, Cupertino, CA). The quantity of cell-associated DBP was estimated by interpolation from the linear portion ofstandard curve generated using highly purified plasma-derived DBP (0.1,0.5,2,5, and 10 ng). The mean standard curve (r = .988) was generated from three separate western blots. The curve remained linear up to 20-ng DBP. Each analysis of cell lysates contained lanes with 10 ng and 2 ng purified DBP as internal standards to control for blot-to-blot variations in band intensity.
RESULTS

Ident$cation of DBP in human neutrophils. Viable, in-
tact human neutrophils show a strong cell-surface reactivity with a monospecific, polyclonal goat antihuman DBP (Fig 1  A) . Greater than 95% of the cells displayed a prominent rim pattern of fluorescence. Furthermore, staining was greatly enhanced if the cells first were pretreated with purified plasma-derived DBP (data not shown). Control cell preparations treated with nonimmune goat IgG followed by FITClabeled rabbit antigoat IgG essentially showed no fluorescent staining (Fig 1B) . The nuclear staining observed in both anti-DBP and nonimmune IgG treated cells was caused by p-phenylenediamine in the mounting media that was added to distinguish nuclear morphology. It is interesting to note that in contrast to the polyclonal anti-DBP, neutrophils reacted with a mouse monoclonal IgG, to human DBP (MAK-89) displayed very poor cell-surface staining (data not shown).
To determine the molecular weight of the cell-associated DBP, detergent-soluble neutrophil lysates were subjected to SDS-PAGE followed by Western blotting with anti-DBP. Relatively similar amounts of immunoreactive DBP are present in the detergent-soluble lysate of neutrophils obtained from several healthy donors (Fig 2) . No immunoreactive bands were noted in the detergent-insoluble cell pellet (data not shown). The major immunoreactive band in the detergent-soluble lysates comigrated at the same apparent molecular weight as purified plasma-derived DBP, ie, approximately 56 Kd under reducing conditions. In addition, a second less prominent immunoreactive band with a molecular weight of approximately 12 to 14 Kd usually was observed, even though the cells were lysed in the presence of a large quantity of protease inhibitors (Fig 2) . The 12 to 14 Kd band was observed even in cells treated with 10 mmol/L 
data not shown), indicating that this fragment was not linked to the remainder of the DBP molecule by one of 14 disulfide bonds. Several minor immunoreactive bands occasionally were noted between the 12 to 14 and 56-Kd bands and may have been generated by proteolytic degradation of the 56-Kd band. Because the detection system for the Western blots used an alkaline phosphatase linked secondary antibody, there was the concern that the bands detected as neutrophil-associated DBP may be caused by either: ( I ) cellderived alkaline phosphatase that reacted with the BCIP-NBT substrate and/or; (2) cell-associated human IgG that was detected by the secondary antibody (rabbit antigoat IgG). However, when neutrophil lysates from the equivalent of IO' cells (twofold to fivefold over the amount typically examined) were separated by SDS-PAGE and blotted onto PVDF paper, no bands developed when the blot was reacted with either BCIP-NBT substrate alone or secondary antibody plus substrate, thereby largely discounting the concerns noted above (data not shown). Immunoprecipitation of DBP from neutrophil lysates using polyclonal goat anti-DBP showed a prominent band at 56 Kd (Fig 3, lane 2) and lysates depleted of DBP by prior immunoprecipitation showed essentially no immunoreactive bands (Fig 3, lane I) . In addition, the lack ofimmunoreactive bands in lysates depleted of DBP provides further evidence that the detection system specifically identifies DBP (Fig 3, lane I) . Because DBP can be readily immunoprecipitated from cell lysates, surface radioiodination followed by immunoprecipitation of detergent-soluble lysates was used to examine cell-surface DBP (Fig 4) . DBP immunoprecipitated from surface-labeled untreated neutrophils using the MAK-89 monoclonal anti-DBP showed a 12-to 14-Kd-labeled band (Fig 4, lane 2) . However, cells first pretreated with purified plasmaderived DBP before radioiodination displayed both the 56-Kd and 12-to 14-Kd forms (Fig 4, lane I) . There was no radiolabeling of intracel- Localization of DBP in human neutrophils. To identify the subcellular distribution of DBP in human neutrophils, five subcellular fractions were isolated by centrifugation on discontinuous Percoll gradients after the cells were disrupted by nitrogen cavitation. Immunoreactive DBP at 56 Kd was primarily found in the plasma membrane fraction (Fig 5, lane 1) and in the fraction that contained the specific (secondary) granules (Fig 5, lane 5) . Essentially identical results were obtained using neutrophil subcellular fractions prepared from two other donors (total n of 3). Although the subcellular fractions were 85% to 90% pure as assessed by the enzymatic and binding activity of the markers (data not shown), the cytosolic fraction (Fig 5, lane  3) shows some weak immunoreactive bands at and below 56 Kd. These bands could be caused by a slight contamination from the plasma membranes during the postcentrifugation fraction collection. Because DBP appeared to be localized to specific granules and cell membranes, we next investigated whether the granule-associated DBP could be upregulated to the cell surface on stimulation with the receptor-independent stimulus PMA. PMA is known to be an effective agent for the release of specific granule contents but a poor inducer of azurophil (primary) degranulation." Pretreatment of neutrophils with IO nmol/L PMA reduced the relative amount of DBP in both the specific granule (Fig 6, lane I ) and plasma membrane fraction (Fig 6, lane 2) versus those from the untreated neutrophils (Fig 6, lanes 3 and 4) . A separate experiment using PMA-pretreated neutrophils obtained from a different donor produced an identical pattern of intracellular and membrane DBP diminution (data not shown).
Finally, to determine if DBP was released into the extracellular milieu from specific granules and/or the plasma membrane, cell-free supernates (ie, releasates) of neutrophils were examined for the presence of immunoreactive DBP (Fig 7) . DBP was released into the cell-free supernates nmol/l-C5a (lanc 4). Maximal lcvcls of immunorcactivc DRP wcrc notcd in thc cell-frcc supcrnatcs aftcr 45 minutes of incubation with the stimuli (Fig 7) . Ncutrophils prctrcatcd with I pmol/L IYLP also rclcascd csscntially idcntical amounts of DRP into thc supcrnatc as thosc prctrcatcd with C5a (data not shown). It is intriguing to notc that DRP appcarcd to bc spontaneously rclcascd bccausc huffcrtrcated cclls incuhatcd for 45 minutes at 37°C rclcascd a considcnhlc quantity of DRP (compare lanc 3 I' lancs 2 and 4). Although thc major DRP hand in thc rclcasatcs was at 56 Kd. it rcprcscnted only 40'; to 50'7 ofthc total immunorcactivc material. Rccausc protcasc inhihitors wcrc not prcscnt during thc incuhation (they wcrc addcd at thc cnd of thc incubation pcriod). many of thc hands hclow 56 Kd may haw bccn generatcd by clcavagc of DRP by protcascs rclcascd from thc granulcs. Indeed. at incubation timcs longcr than 45 minutes. Icvcls of 56-Kd DRP dccrcascd and thc numbcr of low molccular wcight immunorcactivc hands incrcascd (data not shown). Thc rclcasatcs from PMA-stimulatcd- (Fig 7. lanc 2) and C5a-stimulatcd- (Fig 7. lanc 4) ncutrophils also displaycd a discrete immunorcactivc band grcatcr than 56 Kd. This hand (molccular wcight cstimatcd at 75 Kd) \vas ohscrvcd in four scparatc experiments in which ncutrophil rclcasatcs wcrc analy7cd by Wcstcrn hlotting. Howcvcr. this form of DRP has only bcen obscrvcd in rclcasatcs and ncvcr dctcctcd in dctcrgcnt lysatcs of ncutrophils. this DRP was almost cxclusivcly distributed bctwccn thc spccific granulcs (34"; 2 3"; of thc total. n = 3) and plasma mcmhranc (66q 2 4"; of thc total. n = 3) (scc Fig 5) . Stimulation of ncutrophils with 10 nmol/L PMA for I5 minutes at 37°C did not altcr thc pcrccnt distribution of DRP hut dccrciiscd thc amount in both thc spccific granulcs and plasma mcmhranc hy approximatcly 50f.i (scc Fig 6) .
Total immunorcactivc DRP rclcascd into the ccll-frcc supcrnatcs was mcasurcd using a quantitative slot blot proccdurc ( n 3). DRP rclcascd hy prctrcatmcnt of neutrophils (IO' cclls) with cithcr huffcr. C5a (IO nmol/L). IYLP ( I pmoI/L). or PMA ( 10 nmol/l-) w:is mcasurcd asa pcrccnt of thc total DRP (1005) in a 2"; VP-40 lysatc. Rcsults also wcrc compared with thc total amount of vitamin R,, hinding protein (R,, hp) in thc samc srimplcs. Incubation ofcclls for 45 minutes at 37°C in thc prcscncc of huffcr (HRSS) alonc induccd ncutrophils to rclcasc 30r; ? 4 5 DRP and 225 2 4''; R,, hp. Stimulation with C5a incrcascd thc rclcasc of DRP to 48'; A 5"; ofthc total (645 2 3";. for R,2 hp). N L P induccd 46'; ~tr 7c; DRP rclcasc ( 6 W 2 .Crh R,, hp). and trcatmcnt with PMA produccd thc most DRP in thc rclcasatc at 64"; rc: 8"; (82"; A 4"; rclcasc for R,, bp).
DISCUSSION
Ycutrophils contain numcrous ccll-surface and intraccllular molcculcs that scrvc various antimicrobial and proinflammatory functions. In this report. cvidcnce is prcscntcd that normal human ncutrophils contain DRP on thc ccll surfacc and in an intraccllular pool. Thc majority of this ccll-associatcd DRP migrzitcd at thc samc apparent molccular wcight (hy SDS-PAGE undcr rcducing and nonrcducing conditions) as purified plasma-dcrivcd I>RP (56 Kd). Thc origin of neutrophil-associatcd DRP is not yct known. Howcvcr. it sccms unlikcly that maturc circulating ncutrophils synthcsizc DRP bccausc R and T lymphocytcs. both of which haw a much grcntcr capacity for protein hiosynthcsis than maturc ncutrophils. show no stahlc m-RNA transcripts for DRP whcn analy7cd by rcvcrsc transcriptase polymcrasc chain reaction (PCR)." Rccausc ncutrophils havc a vcry limited capacity for dc novo protein hiosynthcsis. and arc short-livcd cnd-stagc cclls. thc hulk of ncutrophil-
proteins are believed to be synthesixd and packaged during myeloid development. Therefore. the most likely source for neutrophil-associated DRP is either ( I ) preexisting pool formed during development in the bone marrow (RM). and/or (2) acquisition ol'DRP by endocytosis while the circulating neutrophil is bathed in plasma. Recause of the limitations described above. these possibilities will be very difficult to test using mature neutrophils and investigations will probably require RM-derived prccursors to define the origin of neutrophil-associated DRP.
Although the majority of the cell-associated DRP has a Fig  4) . In addition. immunofluorescent studies of live. intact neutrophils showed that the polyclonal antibodies. but not the MoAb. can readily detect cell-surface DRP (see Fig I) .
However Kd DBP covalently linked to a cellular macromolecule. To our knowledge, this is the first report of a form of human DBP with a molecular weight higher than intact plasmaderived DBP (ie, 56 Kd). These alternate forms of DBP (12 to 14 Kd and 75 Kd) need to be explored more fully to ascertain their origin and function. Although DBP was detected in subcellular fractions that contained markers for the specific granules and plasma membranes, neutrophil-associated DBP actually may be located in a subset of granules known as secretory vesicles.
Borregaard et have shown that human neutrophils contain a subset of intracellular granules whose contents are rapidly mobilized to the cell surface and extracellular environment. Secretory vesicles (which band between the specific granule and plasma membrane fractions on discontinuous Percoll gradient centrifugation) appear to be an intracellular store for alkaline phosphatase, cytochrome b559r adhesion proteins, and chemotactic factor recep Recently, this group has shown that secretory vesi--56 kD -12 kD cles also contain certain plasma proteins, in particular, albumin, transferrin, and IgG.3' Therefore, considering the above properties ofsecretory vesicles and the fact that neutrophil-associated DBP was detected in both the Plasma membrane and specific granule fractions, and was readily mobilized to the cell surface and extracellular milieu. cell- adhesion molecules34 are located on t h e cell surface and in an intracellular pool and are upregulated t o t h e cell surface and/or shed into the extracellular microenvironment on stimulation. Although it has been shown that plasma-derived DBP regulates t h e chemotactic activity o f complement peptides C5a a n d C5a des Arg?z-26 the role of neutrophil-associated DBP in this process remains unclear. In conclusion, this paper provides the first comprehensive and quantitative report of cell-associated DBP in h u m a n neutrophils, information that is essential for future studies designed to determine the role(s) o f neutrophil-associated DBP.
